Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:activities |
gptkb:monoclonal_antibody
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:developed_by |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:effective_date |
2021-03-26
approved |
| https://www.w3.org/2000/01/rdf-schema#label |
BLA-201
|
| gptkbp:indication |
treatment of relapsed or refractory multiple myeloma
|
| gptkbp:manager |
intravenous
|
| gptkbp:social_structure |
Ig G1 monoclonal antibody
|
| gptkbp:targets |
gptkb:healthcare_organization
|